GlaxoSmithKline Shs Sponsored American Deposit Receipt Repr 2 Shs $46.80

down -0.52


23/9/2014 12:01 PM  |  NYSE : GSK  
Industries : Drugs / Drug Manufacturers - Major
Get Trend Analysis Icon Get GSK Trend Analysis - it has underperformed the S&P 500 by 23%

Partner Headlines

  1. Could European Funds Offer An Opportunity Now?

    Benzinga
  2. Widely Held Guru Stocks Trading In Europe

    GuruFocus
  3. 3 Partnerships Pushing The Pharmaceutical Sector Forward

    Benzinga
  4. Guru Stocks at 52-Week Lows: BHP, GSK, EC, VALE, ABB

    GuruFocus
  5. China Fines Glaxo For Bribes

    IBD
  6. Guru Stocks at 52-Week Lows: BHP, GSK, VOD, LYG, TEF

    GuruFocus
  7. Stock Futures Down, But Not Far; Alibaba Sets IPO Price Range

    IBD
  8. Benzinga's M&A Chatter for Wednesday August 27, 2014

    Benzinga
  9. GSK Receives FDA Approval Of An Additional Promacta (eltrombopag) Indication ...

    Benzinga
  10. InterMune Stock Spikes On Rare Big Biotech Buyout

    IBD
  11. 3 Dividend Kings From The U.K. I Love To Buy

    GuruFocus
  12. UPDATE: GlaxoSmithKline Receives FDA Approval For Arnuity Ellipta In US ...

    Benzinga
  13. Guru Stocks at 52-Week Lows: PFE, GSK, VOD, EC, MFG

    GuruFocus
  14. Intermune up on buyout buzz

    IBD
  15. You Should Consider Adding GlaxoSmithKline Based on Tremendous ROE

    GuruFocus
  16. Drugmaker AstraZeneca Returns To Growth

    IBD
  17. Widely Held Guru Stocks Near 52-Week Lows

    GuruFocus
  18. Pfizer To Buy Baxter's Vaccines For $635 Million: The Positives & Negatives

    Benzinga
  19. Glaxo, Sanofi Trend Up On Potential Deal For Established Brands

    Benzinga
  20. Guru Stocks at 52-Week Lows: PFE, GSK, VOD, EC, UBS

    GuruFocus
  21. Glaxo, Genmab Report Positive Interim Result for Phase III Study of Ofatumumab

    Benzinga
  22. A Look at the Week's Top Dividend Growers

    GuruFocus
  23. Markets Little Changed Ahead Of The Federal Reserve's Policy Decision

    Benzinga
  24. GlaxoSmithKline

    IBD
  25. Stock Futures Up, But Wobbly; Boeing, Apple, Biogen Rising

    IBD
  26. Mylan Wins Motion To Enjoin GlaxoSmithKline From Providing Paroxetine CR ...

    Benzinga
  27. Morning Market Movers

    Benzinga
  28. Top 4 NYSE Stocks In The Drug Manufacturers-Major Industry With The Highest ...

    Benzinga
  29. Highest Yielding Stocks Widely Held By The Gurus

    GuruFocus
  30. British Stocks: Sweet Spot For European Value

    YCharts
  31. Diamond Hill Capital Comments on GlaxoSmithKline PLC

    GuruFocus
  32. ISIS Pharma Trades Up Premarket; NYT Says Has Potential Heart Attack Drug

    Benzinga
  33. Advances In HIV, Hep C Treatments Could Spark Renewed Interest In Biotech ...

    Benzinga
  34. InterMune Up On Bullish View Of U.S. Esbriet Launch

    IBD
  35. UPDATE: Glaxo, Theravance Report Positive Data from Two Studies Considering ...

    Benzinga
  36. Major British Companies Lead Top Guru-Held UK and Ireland Stocks

    GuruFocus
  37. ASCO Meeting Day 3: Do More Treatments Equal A Longer Life?

    Benzinga
  38. ASCO Meeting Day 2: 'Promising' Results From JNJ's Imbruvica & Targeted ...

    Benzinga
  39. Aura Of Light Shines On Pernix Shares Following Treximet Acquisition

    Benzinga
  40. Cross-Border Megamergers Drive Global Takeover Boom

    IBD
  41. Google Celebrates Dorothy Hodgkin & Her Contributions To Chemistry

    Benzinga
  42. Can Pfizer Make Up Its Loss?

    GuruFocus
  43. Merck Sells Consumer Unit To Bayer To Focus On R&D

    IBD
  44. Bayer Buys Merck Consumer Care Unit

    FoxBusiness
  45. AstraZeneca Rejects Pfizer's $106B Buyout Bid

    FoxBusiness
  46. #PreMarket Primer: Thursday, May 1: Fed Brushes Off Dissapointing GDP And ...

    Benzinga
  47. Glaxo hurt by Advair scandal

    IBD
  48. Nasdaq Leads Early Stock Slide; Twitter Tumbles, Trinity Rises

    IBD
  49. Stock Futures Slip as Traders Brace for Economic Flood

    FoxBusiness
  50. Disappointing GDP Reading Weighs on Stocks

    FoxBusiness
Trading Center